Description

Company: Hilma Biocare
Active Half-life (Hours): 6 to 8h
Group: Peptide hormone
Subgroup: Injection/powder
Dosage: 2 mg (2000 mcg)
Application (Men): 1000 mcg in 3 to 4 days
Product pack:  1 vial
Content (active): CJC-1295 DAC
Retains water: Yes
Aromatization: No

Product Description:

CJC-1295 DAC, a peptide developed by ConjuChem, made its debut in 2005. Unlike GHRP peptides, CJC-1295 DAC releases growth hormone in a steady and controlled manner, providing a more natural and consistent effect. After a single injection, the hormone concentration in the blood increases by 2-10 times within six days.

Benefits:

Athletes can use CJC-1295 DAC to achieve a range of performance-enhancing benefits, including:

• Increased muscle growth and performance
• Reduced body fat
• Enhanced collagen synthesis for tendon and ligament reinforcement
• Improved overall well-being

Safety:

As a peptide, CJC-1295 DAC does not carry the same risk of adverse reactions associated with anabolic steroids. The most common side effects reported include excessive water retention and weakness.

Stacking:

CJC-1295 DAC can be safely stacked with other peptides, anabolic androgenic steroids (AAS), and human growth hormone (HGH) for enhanced results.